To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.

United States第116届国会HR-3443House of Representatives
更新于：2019年7月24日

摘要

暂无摘要。

法案文本

可用版本
Introduced (House)查看官方文本

有 1 个可用版本

已显示全部可用记录。

时间线

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Sponsor introductory remarks on measure. (CR E971)

已显示全部可用记录。